Sara Bonstein Insmed Inc (INSM) insider trading activity

Sara Bonstein is Chief Financial Officer of INSMED Inc. Currently has a direct ownership of 117,481 shares of INSM, which is worth approximately $8.18 Million. The most recent transaction as insider was on May 29, 2024, when has been sold 220,564 shares (Common Stock) at a price of $50.0 per share, resulting in proceeds of $11,028,200. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 117K

0% 3M change

11.63% 12M change

Total Value Held $8.18 Million

Sara Bonstein Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 29 2024	SELL Open market or private sale	$11,028,200 $50.0 p/Share	220,564 Reduced 65.25%	117,481 Common Stock
May 29 2024	BUY Exercise of conversion of derivative security	$5,792,010 $26.26 p/Share	220,564 Added 38.07%	358,769 Common Stock
May 28 2024	SELL Open market or private sale	$1,036,407 $50.01 p/Share	20,724 Reduced 5.78%	338,045 Common Stock
May 28 2024	BUY Exercise of conversion of derivative security	$544,212 $26.26 p/Share	20,724 Added 5.97%	326,613 Common Stock
May 14 2024	SELL Open market or private sale	$280,748 $25.32 p/Share	11,088 Reduced 8.62%	117,481 Common Stock
May 13 2024	BUY Grant, award, or other acquisition	-	14,518 Added 10.15%	128,569 Common Stock
Jan 09 2024	SELL Open market or private sale	$131,222 $29.18 p/Share	4,497 Reduced 3.79%	114,051 Common Stock
Jan 04 2024	BUY Grant, award, or other acquisition	-	12,873 Added 9.8%	118,548 Common Stock
Dec 22 2023	SELL Open market or private sale	$395,970 $30.0 p/Share	13,199 Reduced 11.14%	105,241 Common Stock
May 16 2023	SELL Open market or private sale	$29,736 $18.47 p/Share	1,610 Reduced 1.35%	117,619 Common Stock
May 15 2023	SELL Open market or private sale	$42,653 $19.3 p/Share	2,210 Reduced 1.82%	119,229 Common Stock
May 11 2023	BUY Grant, award, or other acquisition	-	55,408 Added 31.33%	121,439 Common Stock
Jan 10 2023	SELL Open market or private sale	$51,768 $18.12 p/Share	2,857 Reduced 4.15%	66,031 Common Stock
Jan 05 2023	BUY Grant, award, or other acquisition	-	13,297 Added 16.18%	68,888 Common Stock
May 16 2022	SELL Open market or private sale	$26,525 $18.51 p/Share	1,433 Reduced 2.55%	54,683 Common Stock
May 11 2022	BUY Grant, award, or other acquisition	-	20,137 Added 26.41%	56,116 Common Stock
Jan 11 2022	SELL Open market or private sale	$28,977 $25.11 p/Share	1,154 Reduced 3.11%	35,979 Common Stock
Jan 06 2022	BUY Grant, award, or other acquisition	-	13,006 Added 25.94%	37,133 Common Stock
May 12 2021	BUY Grant, award, or other acquisition	-	14,172 Added 37.76%	23,355 Common Stock
Jan 07 2021	BUY Grant, award, or other acquisition	-	9,183 Added 50.0%	9,183 Common Stock

Also insider at

SCPH

scPharmaceuticals Inc. Healthcare

XLO

Xilio Therapeutics, Inc. Healthcare

Sara Bonstein

Chief Financial Officer

Bridgewater, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INSM shares.

Notify only if

Value

Insider Trading

Get notified when an Insmed Inc insider buys or sells INSM shares.

Notify only if

Operation

Value

Type

News

Receive news related to INSMED Inc

Track Activities on INSM

Account